Statens Serum Institut (English: the State Serum Institute), or SSI for short, is a Danish sector research institute located on the island of Amager in Copenhagen. Its purpose is to combat and prevent infectious diseases, congenital disorders, and threats from weapon of mass destruction. Founded in 1902 in the barracks of the Artillerivej road, it has now expanded to much more than its original size and is now one of Denmark’s largest research institutions in the health sector.
Apart from work in Denmark, Statens Serum Institut is also involved in health promotion and monitoring in Guinea-Bissau, as maintained by the Bandim Health Project. Mainly doctors, pharmaconomists and pharmacists work at the National Serum Institute. A total of 385 people at SSI are engaged in research. SSI contributes each year over 30 master students and 10-15 PhDs.
Statens Serum Institut (SSI) is a governmental public health and research institution under the Danish Ministry of Health, situated in the heart of Copenhagen. SSI prevents and controls infectious diseases, biological threats and congenital disorders based on core competencies within public health, microbiology, immunology, epidemiology and information and communication technology. SSI is the national reference laboratory for microbiology and is the national centre for epidemiology and surveillance of infectious diseases. SSI provides a wide range of services, nationally as well as internationally including consultancies on microbiological and epidemiological monitoring of infectious diseases. SSI provide educational, advisory and reference services, all directed mainly towards the national needs, but also with strong international scope. Internationally SSI carries out a large number of advisory and reference functions for the WHO and the EU. SSI is an official Danish contact point and Competent Body for the European Centre for Disease Control and Prevention, ECDC and the National Focal Point for WHO International Health Regulations 2005. Foreign health services and individual doctors may request for general advice or special analyses and expert typing of particular micro-organisms which defy identification in their own laboratories. The SSI includes the Danish Centre for Biosecurity and Biopreparedness (CBB) which is the national authority that issues licenses to research institutions pharmaceutical companies, hospital laboratories etc. to allow then to work with biological dual use components. This centre also maintains a 24/7 response capability to counter the effects of a biological incident whether of accidental or malicious origins.SSI is a major European research centre engaged in a broad array of collaborations with sister organizations in other countries, institutions, companies and health research centres throughout the world. EUPHEM fellows will receive their training in Division for Diagnostics and Infection Control which holds a range of departments and specialized units covering all aspects of bacteriology including tuberculosis and biohazard III organisms, virology, parasitology and mycology. SSI aims to ensure advanced control of infectious diseases, including new infections and biological threats. The Institute also strives to be a highly regarded and recognized national and international research, production and service enterprise.